Connect with us

Technology

AI in Life Sciences Market Poised for Explosive Growth with 27.9% CAGR Through 2029

Published

on

AI Revolutionizes Life Sciences: Transforming Drug Discovery, Personalized Medicine, and Patient Outcome. BCC Research Study Projects a 27.9% CAGR, with Market Growth from $9.8 Billion in 2024 to $33.5 Billion by 2029

BOSTON, Sept. 26, 2024 /PRNewswire/ — “According to the latest BCC Research study, the demand for “Artificial Intelligence (AI) in Life Sciences Market” is estimated to grow from $9.8 billion in 2024 to $33.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.”

The global artificial intelligence (AI) in the life sciences market is witnessing significant growth, driven by advancements in AI technologies and their increasing adoption across the life sciences sector. This report provides a comprehensive analysis of the market size, estimating both current and historical revenues segmented by products, applications, end users, and regions. By examining these factors, the report offers insights into the evolving landscape of AI in life sciences, highlighting key trends and regional dynamics that are shaping the future of this transformative field.

This report is particularly relevant at this moment due to the rapid advancements and accelerating adoption of artificial intelligence within the life sciences industry. As the volume and complexity of biological data continue to increase, there is a pressing need for innovative technologies that can enhance our ability to understand, diagnose, and treat various diseases. AI is at the forefront of these advancements, offering transformative potential to revolutionize healthcare by enabling more precise and efficient solutions. The global COVID-19 pandemic has further emphasized the importance of AI, highlighting its critical role in speeding up drug discovery, developing vaccines, and improving diagnostic tools. With these unprecedented challenges and opportunities, this report provides essential insights into the current state and future impact of AI in life sciences, making it a valuable resource for stakeholders seeking to navigate and capitalize on this rapidly evolving field.

Please click here for more details on “The global market for artificial intelligence (AI) in life sciences products Report.”

The following factors drive the global market for artificial intelligence (AI) in life sciences products:

Increasing Adoption of AI-Driven Solutions for Drug Discovery and Development: AI is transforming the drug discovery and development landscape by drastically cutting down the time and costs traditionally associated with these processes. Where conventional methods might take years and billions of dollars, AI can swiftly analyze large datasets to pinpoint potential drug candidates and forecast their efficacy and safety. This accelerates the preliminary stages of drug discovery, enabling researchers to concentrate on the most promising compounds. Moreover, AI aids in refining clinical trial designs, identifying appropriate patient groups, and predicting trial outcomes, further expediting the development pipeline.

Rising Need for Precision Medicine and Personalized Treatment Approaches: Precision medicine focuses on tailoring medical treatments to the unique characteristics of each patient. AI is instrumental in this process by analyzing genetic, environmental, and lifestyle factors to determine the most effective treatment strategies for individual patients. This personalized approach leads to improved patient outcomes, as therapies are specifically crafted to address the distinct aspects of a patient’s condition. Additionally, AI allows for real-time monitoring of patient responses, enabling rapid adjustments to treatment plans when needed. This level of customization is becoming increasingly vital as healthcare shifts towards more patient-centered models.

Request a sample copy of the global market for artificial intelligence (AI) in life sciences products report:

Report Synopsis

Report Metrics

Details

Base year considered

2023

Forecast Period considered

2024-2029

Base year market size

$8.0 billion

Market Size Forecast

$33.5 billion

Growth rate

CAGR of 27.9% from 2024 to 2029

Segment Covered

By Product Segment, Application, End User, and Region

Regions covered

North America, Europe, Asia-Pacific, and the Rest of the World (RoW)

Key Market Drivers

•  Increasing adoption of AI-driven solutions for drug discovery and development

•  Rising need for precision medicine and personalized treatment approaches

 

Key Interesting Facts About the global market for artificial intelligence (AI) in life sciences products:

1.  AI in Drug Discovery and Development:

AI accelerates drug discovery by rapidly screening millions of compounds.It generates novel drug candidates, transforming drug development.Virtual clinical trials streamline research, reducing costs.

2.  AI in Precision Medicine and Medical Imaging:

Precision medicine tailors treatments based on genetic analysis.AI excels in medical imaging analysis, aiding diagnoses.Machine learning detects subtle patterns, aiding early disease detection.

The global market for artificial intelligence (AI) in life sciences products report includes in-depth data and analysis addressing the following important queries:

1.  What is the projected market size and growth rate of Artificial Intelligence (AI) in the Life Sciences market?

The global Artificial Intelligence (AI) In Life Sciences market was valued at $8.0 billion in 2023 and is expected to reach $33.5 billion by the end of 2029, expected to grow at a CAGR of 27.9% from 2024 to 2029.

2.  What are the key factors driving the growth of artificial intelligence (AI) in the life sciences market?

The growth of Artificial Intelligence (AI) in the Life Sciences market is primarily driven by the increasing adoption of AI-driven solutions for drug discovery and development, the rising need for precision medicine and personalized treatment approaches, and the demand for advanced diagnostic tools to analyze complex biological data.

3.  What segments are covered in the global Artificial Intelligence (AI) in the Life Sciences market?

The global Artificial Intelligence (AI) market in the Life Sciences is segmented based on product, application, end-user, and region.

4.  By Type, which segment will dominate the market by the end of 2029?

The software segment will dominate the market by the end of 2029.

5.  Which region has the highest market share in Artificial Intelligence (AI) in the Life Sciences market?

North America holds the highest share of the market.

 Some of the Key Market Players Are:

AICUREAPIXIOATOMWISE INC.BENEVOLENTAIENLITIC INC.NUMEDII INC.RECURSIONZEBRA TECHNOLOGIES CORP.

Browse Related Reports:

Global Markets for Artificial Intelligence in Drug Discovery: This report provides a comprehensive overview of AI in the drug discovery market, analyzing trends from 2020, recent estimates from 2021, and projecting compound annual growth rates through 2028. It focuses on market dynamics such as regulatory scenarios, drivers, restraints, and opportunities, highlighting the potential across applications including preclinical testing, target identification, candidate screening, lead optimization, drug repurposing, and De novo drug design. Therapeutic areas covered include oncology, neurodegenerative diseases, cardiovascular diseases, metabolic diseases, and infectious diseases. Regional analysis spans North America, Europe, Asia-Pacific, and the Rest of the World, with detailed insights into key countries like the U.S., Germany, the U.K., Italy, France, Japan, China, and India.

Directly purchase a copy of the report with BCC Research.

For further information or to make a purchase, please get in touch with info@bccresearch.com

About BCC Research

BCC Research provides objective, unbiased measurement, and assessment of market opportunities with detailed market research reports. Our experienced industry analysts’ goal is to help you make informed business decisions, free of noise and hype.

Contact Us
Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo – https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/ai-in-life-sciences-market-poised-for-explosive-growth-with-27-9-cagr-through-2029–302260398.html

Continue Reading

Technology

Trimble for Government Achieves ‘Initial Implementation’ Status for FedRAMP Class C (Moderate) Certification

Published

on

By

Milestone accelerates secure cloud adoption for federal, state and local entities managing infrastructure, spatial data and capital assets 

WESTMINSTER, Colo., Oct. 20, 2026 /PRNewswire/ — Trimble today announced that Trimble for Government is listed as ‘Initial Implementation’ status for Federal Risk and Authorization Management Program (FedRAMP®) Class C (Moderate) certification and is now listed on the FedRAMP Marketplace. In conjunction with seeking FedRAMP certification, Trimble is also pursuing GovRAMP authorization to support state, local and education (SLED) customers with reciprocal cybersecurity compliance standards.

This dual milestone marks a critical step forward in delivering a software as a service (SaaS) cloud environment built within a secure Government Community Cloud. Designed specifically for U.S. Federal Government departments, state and local agencies, and defense and civilian contractors, Trimble for Government provides a unified ecosystem for managing infrastructure, spatial data, capital projects, permitting and facility assets across their entire lifecycle.

Achieving FedRAMP Class C (Moderate) and GovRAMP alignment will enable public sector entities and Department of Defense (DoD) contractors to comply with stringent security mandates — including Cybersecurity Maturity Model Certification (CMMC) alignment — while modernizing digital engineering and asset management.

“Federal, state and local agencies face the dual challenge of modernizing critical infrastructure while maintaining uncompromising cybersecurity standards,” said Mark Schwartz, group president, AECO at Trimble. “Achieving ‘Initial Assessment’ status reflects our commitment to delivering mission-critical spatial, capital project and asset management capabilities inside a secure, audit-ready cloud boundary across all levels of government.”

Integrated cloud solutions built for government operations

The in-scope environment brings together Trimble’s proven field execution, asset, project and permitting software into four modular packages designed to support specific public sector outcomes:

Trimble® Field Collaboration: Delivers field data services using foundational spatial database infrastructure and GIS integration to support high-security field operations, map assets, and enable seamless field-to-cloud workflows across Trimble’s core Field Systems portfolio.Trimble Project Management powered by Trimble ProjectSight® software: Connects design-to-build workflows in the field, providing precision data layout, project tracking, collaboration and quality assurance across construction projects.Trimble Asset Management powered by Trimble Unity™ Maintain software: Serves as a centralized facilities data core for federal, state, and local government agencies, military installations, and public infrastructure — such as public buildings, utilities, and transportation networks — to optimize maintenance and long-term capital planning.Trimble Permit Management powered by Trimble Unity Permit software: Streamlines end-to-end management of permitting, licensing, land use and infrastructure rights-of-way in a fully compliant cloud environment.

The unifying in-scope element across all four packages is the Trimble Connect® platform, providing collaboration and a common data environment (CDE) across the Trimble for Government platform.

With assessment processes underway, Trimble continues to advance toward full FedRAMP and GovRAMP authorizations to ensure public sector customers can innovate with confidence.

About Trimble
Trimble is a global technology company that connects the physical and digital worlds, transforming the ways work gets done. With relentless innovation in precise positioning, modeling and data analytics, Trimble enables essential industries including construction, geospatial and transportation. Whether it’s helping customers build and maintain infrastructure, design and construct buildings, optimize global supply chains or map the world, Trimble is at the forefront, driving productivity and progress. For more information about Trimble, visit: www.trimble.com.

GTRMB

View original content to download multimedia:https://www.prnewswire.com/news-releases/trimble-for-government-achieves-initial-implementation-status-for-fedramp-class-c-moderate-certification-302913499.html

SOURCE Trimble

Continue Reading

Technology

Trimble for Government Achieves ‘Initial Implementation’ Status for FedRAMP Class C (Moderate) Certification

Published

on

By

Milestone accelerates secure cloud adoption for federal, state and local entities managing infrastructure, spatial data and capital assets 

WESTMINSTER, Colo., Oct. 20, 2026 /PRNewswire/ — Trimble today announced that Trimble for Government is listed as ‘Initial Implementation’ status for Federal Risk and Authorization Management Program (FedRAMP®) Class C (Moderate) certification and is now listed on the FedRAMP Marketplace. In conjunction with seeking FedRAMP certification, Trimble is also pursuing GovRAMP authorization to support state, local and education (SLED) customers with reciprocal cybersecurity compliance standards.

This dual milestone marks a critical step forward in delivering a software as a service (SaaS) cloud environment built within a secure Government Community Cloud. Designed specifically for U.S. Federal Government departments, state and local agencies, and defense and civilian contractors, Trimble for Government provides a unified ecosystem for managing infrastructure, spatial data, capital projects, permitting and facility assets across their entire lifecycle.

Achieving FedRAMP Class C (Moderate) and GovRAMP alignment will enable public sector entities and Department of Defense (DoD) contractors to comply with stringent security mandates — including Cybersecurity Maturity Model Certification (CMMC) alignment — while modernizing digital engineering and asset management.

“Federal, state and local agencies face the dual challenge of modernizing critical infrastructure while maintaining uncompromising cybersecurity standards,” said Mark Schwartz, group president, AECO at Trimble. “Achieving ‘Initial Assessment’ status reflects our commitment to delivering mission-critical spatial, capital project and asset management capabilities inside a secure, audit-ready cloud boundary across all levels of government.”

Integrated cloud solutions built for government operations

The in-scope environment brings together Trimble’s proven field execution, asset, project and permitting software into four modular packages designed to support specific public sector outcomes:

Trimble® Field Collaboration: Delivers field data services using foundational spatial database infrastructure and GIS integration to support high-security field operations, map assets, and enable seamless field-to-cloud workflows across Trimble’s core Field Systems portfolio.Trimble Project Management powered by Trimble ProjectSight® software: Connects design-to-build workflows in the field, providing precision data layout, project tracking, collaboration and quality assurance across construction projects.Trimble Asset Management powered by Trimble Unity™ Maintain software: Serves as a centralized facilities data core for federal, state, and local government agencies, military installations, and public infrastructure — such as public buildings, utilities, and transportation networks — to optimize maintenance and long-term capital planning.Trimble Permit Management powered by Trimble Unity Permit software: Streamlines end-to-end management of permitting, licensing, land use and infrastructure rights-of-way in a fully compliant cloud environment.

The unifying in-scope element across all four packages is the Trimble Connect® platform, providing collaboration and a common data environment (CDE) across the Trimble for Government platform.

With assessment processes underway, Trimble continues to advance toward full FedRAMP and GovRAMP authorizations to ensure public sector customers can innovate with confidence.

About Trimble
Trimble is a global technology company that connects the physical and digital worlds, transforming the ways work gets done. With relentless innovation in precise positioning, modeling and data analytics, Trimble enables essential industries including construction, geospatial and transportation. Whether it’s helping customers build and maintain infrastructure, design and construct buildings, optimize global supply chains or map the world, Trimble is at the forefront, driving productivity and progress. For more information about Trimble, visit: www.trimble.com.

GTRMB

View original content to download multimedia:https://www.prnewswire.com/news-releases/trimble-for-government-achieves-initial-implementation-status-for-fedramp-class-c-moderate-certification-302913499.html

SOURCE Trimble

Continue Reading

Technology

Delta Development Team and The Good Drone Company Awarded U.S. Army Contract for Aerial Blood Delivery

Published

on

By

TUCSON, Ariz., Oct. 20, 2026 /PRNewswire/ — Delta Development Team (DDT), a leader in prehospital blood storage and cold chain technology, and The Good Drone Company (GDC) have been awarded a U.S. Army contract to develop a drone-based blood delivery capability for the Army Blood Link (ABL) program.

The program is part of the broader Armed Services Blood Program (ASBP), which supplies blood products to U.S. military forces worldwide. Army Blood Link is designed to support battlefield medical logistics through rapid, temperature-controlled delivery of lifesaving blood products to the field, providing an additional resupply option when traditional ground transportation is unavailable, delayed, or unsafe. Under the contract, The Good Drone Company will provide two U.S.-built prototypes of its hybrid vertical takeoff and landing (VTOL) cargo drone, each designed to transport up to six units of blood, while DDT will provide the temperature-controlled storage capability through its Delta ICE 2L Smart Blood Cooler.

The companies are combining commercial off-the-shelf (COTS) technologies to create a U.S.-sourced aerial blood delivery system capable of transporting blood directly to the point of need.

To meet ABL program requirements, DDT will supply six Delta ICE 2L Smart Blood Coolers, each designed to maintain two units of blood within the required temperature range for three hours of aerial delivery in high-humidity environments with ambient temperatures ranging from 15°F to 120°F. Built-in temperature monitoring and data recording, along with Bluetooth and cellular connectivity, support cold-chain oversight and blood accountability. The program extends DDT’s blood storage and monitoring capabilities into aerial delivery.

“Getting blood to the point of need is only part of the challenge. It must also remain within the required temperature range throughout the journey,” said Montgomery Leija, CEO of Delta Development Team. “This program brings DDT’s experience in blood storage and cold chain management into a new operational environment, taking the blood supply chain from the ground to the air.”

The prototype system is designed to deliver blood within 10 meters of a designated target during both day and night operations. It will feature a communications range of up to 30 miles and semi-autonomous waypoint navigation. It is intended for single-person operation with minimal training and is built on GDC’s existing commercial cargo drone technology to accelerate development and fielding while meeting U.S.-sourcing requirements.

“We have seen strong interest in middle-mile drones in emerging markets for some time, from both public and private sector customers spanning healthcare to third-party logistics,” said Jake Vander Ploeg, CEO of The Good Drone Company. “This program is a great example of how the military is adopting commercial technology like our cargo drones to quickly test new ideas in the field without starting a full aircraft development program.”

The collaboration combines GDC’s expertise in commercial drone platforms and aerial delivery with DDT’s temperature-controlled blood storage and transport capabilities to support:

Rapid resupply: Delivering blood when conventional ground transportation is unavailable or unsafe.Cold chain protection: Maintaining required blood temperatures during aerial transport.U.S.-sourced capability: Supporting domestic defense supply chain objectives.Accelerated development: Combining GDC’s existing commercial cargo drone technology with DDT’s established blood storage solutions.

The ABL effort addresses the challenge of delivering critical medical supplies in contested and austere environments. When terrain, damaged infrastructure, or tactical conditions prevent conventional resupply, aerial delivery combined with temperature-controlled storage can expand options for getting lifesaving blood products to service members when and where they are needed.

About Delta Development Team

Delta Development Team (DDT) is a U.S.-based medical technology company headquartered in Tucson, Arizona, specializing in blood storage, transport, monitoring, and logistics solutions for military and prehospital environments. DDT develops technology designed to keep blood available, traceable, and mission-ready from the blood bank to the point of injury. Its portfolio includes the APRU 6L, Delta ICE 2L, TBS 40L, and BloodCOMM® blood management platform.

Media Contact: info@deltadevteam.com | www.deltadevteam.com

About The Good Drone Company

The Good Drone Company (GDC) is an aerospace company headquartered in Tempe, Arizona, that designs and builds autonomous hybrid VTOL cargo drones for middle-mile logistics. GDC’s aircraft take off and land vertically without a runway, carry up to 55 lb (25 kg) of payload, and fly more than 300 miles (500 km) at speeds up to 93 mph (150 km/h). GDC is deploying in Kenya to close the middle-mile transportation gap for public and private sector customers, working closely with its local partner ThatcherX and the Kenyan government to change how goods move around the country.

Media Contact: info@thegooddronecompany.com | www.thegooddronecompany.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/delta-development-team-and-the-good-drone-company-awarded-us-army-contract-for-aerial-blood-delivery-302913294.html

SOURCE Delta Development Team

Continue Reading

Trending